The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months.View on ...

NICE’s decisions for both drugs are not final and are pending more evidence. Credit: Art_Photo via Shutterstock. · Clinical ...

There are four dementia-specific medications approved in Australia – donepezil, galantamine, rivastigmine, and memantine.

As we start looking to the year ahead, the pharma industry is gearing up for a slate of new drug launches and U.S. Food and ...

Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2 diabetes, ...

The UK’s AstraZeneca, which is working on an oral GLP-1, also views the drugs as part of a combination strategy. In other ...

A new Alzheimer’s treatment from US firm Eli Lilly was approved for use this week by the UK drug regulator MHRA, although disappointingly for its maker, the drug won’t be available on the NHS as it ...

Lina Polimeni, chief corporate brand officer at Lilly, notes that public perception of the company has historically been ...

Global Gene Therapy in CNS Disorder IndustryThe global gene therapy market for central nervous system (CNS) disorders is set ...

Southwest Airlines settles with activist to end proxy fight, Novo Nordisk’s Ozempic might reduce Alzheimer’s risk, and more ...

The boom experienced by the weight loss drug market comes as little surprise when considering that almost a third of the ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.